aspirin should be served or not for diabetic patients (part 1)

Diabetic patients the risk of cardiovascular adverse events than people without diabetes to be higher than 2 times to 4 times. Over the years, aspirin was almost all the international guidelines recommended for the prevention of diabetes in diabetic cardiovascular and cerebrovascular disease. Recommended guidelines for more than 40 years of age and under 40 years of age but the risk factors of cardiovascular disease in type 2 diabetic patients, aspirin should be routine.

Many diabetic patients in order to prevent cardiovascular and cerebrovascular diseases, will be the prevention of aspirin as a regular medication, but recent news has caused two of the doubt and panic patients.

Press review

1: aspirin should not reduce the risk of type 2 diabetes the risk of cardiovascular disease

November 12 published in the Journal of the American Medical Association on a study, using low-dose aspirin as a primary preventive measures, and can not be reduced in patients with type 2 diabetes the risk of cardiovascular adverse events. The study completed by Japanese scholars.

University of Kumamoto, Japan Dr. Hisao Ogawa of aspirin on atherosclerosis in diabetes prevention trial-level, low-dose aspirin on patients with type 2 diabetes as the prevention of atherosclerosis is the main measures have been useful research. From December 2002 to April 2008, from 163 institutions in Japan 2539 no atherosclerotic disease history of patients with type 2 diabetes were randomly assigned to receive 81 mg per day or 100 mg of low-dose aspirin Afghanistan Lin's group (1262) or non-aspirin group (1277 persons). The median follow-up time was 4.37 years, the main measure of the consequences for atherosclerotic events, including fatal and non-fatal ischemic heart disease, fatal or non-fatal stroke and peripheral arterial disease.

Study follow-up period, there were 154 incidents of atherosclerosis, aspirin group, 68 cases, 86 non-aspirin group, the differences between the two groups was not obvious. Studies have not found the use of low-dose aspirin, is to reduce the risk of type 2 diabetes the risk of cardiovascular disease in patients with an effective primary prevention therapies.


Press review

2. Aspirin can significantly reduce diabetic cardiovascular and cerebrovascular events in patients with mortality

Held in the United States in November of a heart attack at the school reported a new conclusion: the use of primary prevention in low-dose aspirin can significantly reduce the patients with type 2 diabetes mortality in cardiovascular and cerebrovascular events, and does not increase the risk of haemorrhagic .

Through 163 from the Medical Center of Japan 2539 the 30-year-old to 85-year-old patients with type 2 diabetes more than 52 months follow-up survey found that aspirin can significantly reduce cardiovascular and cerebrovascular events in patients with the mortality in diabetic patients can suffered myocardial infarction and stroke disease, such as preservation of life.

Carefully read the two news, the reader is not difficult to find, almost at the same time the news was released, presided over the totally opposite point of view. Even more incredible is that two completely opposite conclusion from the Japanese scholar has done clinical research with a. This is how in the end all about? Also in the diabetic patients in the end it should not take aspirin?